Clemens Vera, Regen Francesca, Le Bret Nathalie, Heuser Isabella, Hellmann-Regen Julian
Department of Psychiatry, Section Clinical Neurobiology, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.
J Alzheimers Dis. 2018;61(4):1295-1300. doi: 10.3233/JAD-170823.
Apolipoprotein E (ApoE) represents a pivotal target in Alzheimer's disease (AD) and is modulated through retinoic acid (RA), an endogenous neuroprotective and anti-inflammatory compound. A major source of ApoE are microglia, which are pathologically activated in AD. Activated microglia are known to block RA signaling. This suggests a vicious cycle between inflammation, RA signaling, and ApoE homeostasis in AD pathogenesis. To test this hypothesis, we investigated effects of RA and proinflammatory activation on ApoE synthesis in primary human macrophage-derived microglial-like cells. Our results indicate that proinflammatory activation attenuates ApoE synthesis, an effect blocked by RA.
载脂蛋白E(ApoE)是阿尔茨海默病(AD)的关键靶点,并且可通过视黄酸(RA)进行调节,视黄酸是一种内源性神经保护和抗炎化合物。ApoE的主要来源是小胶质细胞,其在AD中会发生病理性激活。已知活化的小胶质细胞会阻断RA信号传导。这表明在AD发病机制中,炎症、RA信号传导和ApoE稳态之间存在恶性循环。为了验证这一假设,我们研究了RA和促炎激活对原代人巨噬细胞衍生的小胶质样细胞中ApoE合成的影响。我们的结果表明,促炎激活会减弱ApoE合成,而这种作用会被RA阻断。